Interventional Cardiology Doctors in Gurugram

Interventional cardiology has redefined what is possible in the treatment of structural and coronary heart disease without open surgery. Coronary arteries that were once bypassed are now opened with balloon catheters and stents. Aortic valves that required cardiopulmonary bypass to replace are now implanted percutaneously through the femoral artery. Mitral regurgitation that demanded a sternotomy is now addressed in selected patients through catheter-delivered clip devices. The sophistication of what is achievable through a catheterisation laboratory has grown considerably - and with it, the technical demands placed on the cardiologist performing these procedures.

The Department of Interventional Cardiology at Medanta - The Medicity, Gurugram is one of the most experienced such departments in the country, led by two Chairmen of Cardiac Care - Dr. Praveen Chandra and Dr. Rajneesh Kapoor - alongside a Senior Director, a Director, an Associate Director, and four Consultants. The combined clinical scope of the team spans every major domain of coronary and structural heart disease intervention, from primary angioplasty and complex coronary procedures to transcatheter valve implantation, congenital heart disease closure, and cerebral and carotid artery stenting.

The department operates within a tertiary cardiac centre that also houses cardiac surgery, cardiac electrophysiology, and clinical cardiology under one institutional programme - a configuration that allows the Heart Team model to function in practice, with joint decision-making between cardiologists and cardiac surgeons for complex structural and coronary cases.

Interventional Procedures Performed at This Department

Complex Coronary Intervention

The department manages the full complexity range of percutaneous coronary intervention ranging from simple single-vessel disease to chronic total occlusions, bifurcation lesions, unprotected left main stem disease, and heavily calcified coronaries requiring modification with rotational atherectomy prior to stent deployment. Intracoronary physiological assessment using fractional flow reserve and instantaneous wave-free ratio guides the decision to intervene, avoiding unnecessary stenting of haemodynamically non-significant lesions. Intracoronary imaging provides vessel wall detail that angiography alone cannot offer, allowing precise stent sizing, positioning and post deployment assessment. Dr. Nagendra Singh Chouhan and Dr. Shashi Kant Pandey both list rotablation, IVUS, FFR and OCT within their procedural scope.

Transcatheter Valve Interventions - TAVI, TMVR, MitraClip, and PTRI

Transcatheter aortic valve implantation - TAVI - replaces the diseased aortic valve through a catheter delivered via the femoral artery, without open surgery or cardiopulmonary bypass. Its indication has expanded progressively from high-risk surgical patients to those at intermediate and, in selected cases, lower surgical risk. Transcatheter mitral valve replacement (TMVR) and the MitraClip procedure address significant mitral regurgitation percutaneously: TMVR through valve replacement and MitraClip through the deployment of a clip device that coapts the leaflets and reduces regurgitant volume. Percutaneous tricuspid valve intervention (PTRI) for significant tricuspid regurgitation rounds out the structural valve portfolio at this department. Dr. Praveen Chandra lists all four transcatheter valve modalities within his practice. Dr. Rajneesh Kapoor and Dr. Tarun Kumar also perform TAVI.

Congenital and Structural Heart Disease Closure

Atrial septal defect closure, ventricular septal defect closure, balloon mitral valvuloplasty for mitral stenosis, balloon aortic valvuloplasty, balloon pulmonary valvuloplasty, and coarctoplasty for aortic coarctation are all performed within the department. These are procedures that sit at the interface between interventional cardiology and structural or congenital heart disease, and require a cardiologist with specific experience in transcatheter device deployment and three-dimensional anatomical orientation. Dr. Rajneesh Kapoor and Dr. Tarun Kumar both list these procedures explicitly.

Peripheral and Cerebrovascular Intervention

Carotid artery stenting, renal artery angioplasty and stenting, peripheral arterial disease intervention and abdominal aortic aneurysm management are all within the department's scope. Dr. Praveen Chandra lists carotid and renal angiography and angioplasty alongside aortic aneurysm management. Dr. Abhinav Chhabra has developed specific expertise in cerebral and carotid artery stenting for stroke patients - a technically demanding subspecialty that requires precise catheter navigation in the cervicocerebral circulation and a thorough understanding of neurological risk during and after the procedure.

The Interventional Cardiology Team

Dr. Praveen Chandra, Chairman of Cardiac Care, holds a DM in Cardiology and an MD in General Medicine. His clinical scope encompasses the full range of transcatheter structural heart interventions including TAVI, TMVR, MitraClip, PTRI alongside complex coronary angioplasty, balloon mitral valvuloplasty, carotid and renal intervention and aortic aneurysm management. He consults at both the Gurugram main campus and the Golf Course Mediclinic.

Dr. Rajneesh Kapoor, Chairman of Cardiac Care, holds a DNB in Cardiology and an MD in Internal Medicine. His practice uniquely spans both cardiac surgery - open heart surgery, congenital heart disease repair and heart transplantation and interventional cardiology, covering TAVI, TMVR, MitraClip, ASD and VSD closure, balloon mitral valvuloplasty, coronary angioplasty, and carotid and renal intervention. This dual surgical and interventional scope positions him particularly well for the Heart Team discussions that govern complex structural cases.

Dr. Nagendra Singh Chouhan, Senior Director, holds a DNB in Cardiology, an MD, and a Fellowship in Interventional Cardiology and Electrophysiology. His procedural focus covers coronary angioplasty, rotational atherectomy, intracoronary imaging and physiology with IVUS, FFR, and OCT, and TAVR. Dr. Gagandeep S Wander, Director, holds a DM in Cardiology and an MD. Dr. Tarun Kumar, Associate Director, completed his DM at Sri Jayadeva Institute of Cardiovascular Sciences and Research Bangalore and his MD at PGI Chandigarh. His scope covers coronary and peripheral intervention, pacemaker and device implantation including ICD and CRT, TAVR, and the full range of valvuloplasty and structural closure procedures.

Dr. Shashi Kant Pandey, Senior Consultant, holds a DM in Cardiology and manages a notably comprehensive clinical scope - complex coronary intervention including CTO, bifurcation and left main lesions; rotablation; IVUS and FFR-guided procedures; permanent and temporary pacemaker implantation; ICD and CRT-D implantation; intra-aortic balloon pump; advanced echocardiography including paediatric echo and strain imaging; Holter and ambulatory blood pressure monitoring; and head-up tilt testing. Dr. Abhinav Chhabra, Consultant, holds a DM and has developed particular expertise in cerebral and carotid artery stenting for stroke management alongside adult and paediatric echocardiography. Dr. Shantanu, Consultant, holds a DM in Cardiology and a DNB in General Medicine. Dr. Tanu Chaudhary, Consultant, holds a DNB in Cardiology - completed at Medanta itself - alongside an MD in Internal Medicine from MLB Medical College Jhansi and MBBS from LLRM Medical College Meerut, and covers coronary angiography, PTCA, structural interventions, pacemaker implantation, and cardiac emergencies.

FAQs

1. What distinguishes TAVI from surgical aortic valve replacement?

   Surgical aortic valve replacement requires a sternotomy, cardiopulmonary bypass, and cardiac arrest during the procedure. TAVI delivers a bioprosthetic valve via a catheter typically through the femoral artery and deploys it within the diseased native valve under fluoroscopic and echocardiographic guidance, with the heart beating throughout. Recovery is substantially faster and the procedural risk is lower in appropriately selected patients. The selection decision - whether TAVI or surgical replacement is preferable for a given patient - is made by a multidisciplinary Heart Team, weighing anatomical suitability, surgical risk score, patient age, expected prosthesis durability, and individual preference. At Medanta Gurugram, this Heart Team discussion involves both the interventional cardiologists and the cardiac surgeons.

2. What is the MitraClip procedure and for whom is it indicated?

   The MitraClip is a catheter-delivered device that addresses significant mitral regurgitation by clipping together the anterior and posterior leaflets of the mitral valve at the point of regurgitation, creating a double-orifice valve configuration that reduces regurgitant volume. It is delivered transvenously, crossing the atrial septum to access the left atrium and the mitral valve. It is indicated in patients with severe symptomatic mitral regurgitation who are at prohibitive or high surgical risk, or in those with functional mitral regurgitation in the context of heart failure where reducing the regurgitant volume is expected to improve symptoms and ventricular remodelling.

3. What is the role of intracoronary imaging in coronary angioplasty?

   Coronary angiography provides a two-dimensional silhouette of the vessel lumen but cannot directly visualise the arterial wall, the plaque composition or the true vessel dimensions. Intravascular ultrasound and optical coherence tomography resolve this limitation by imaging from within the vessel. Intravascular ultrasound (IVUS) uses sound waves to generate cross-sectional images. Optical coherence tomography (OCT) uses near-infrared light and provides higher resolution particularly useful for visualising superficial plaque morphology and stent strut apposition.

4. Is carotid artery stenting safe, and when is it preferable to carotid endarterectomy?

   Carotid artery stenting is a safe and effective treatment in selected patients. Carotid artery stenting is a percutaneous alternative to surgical carotid endarterectomy for the treatment of significant carotid stenosis in patients at risk of stroke. It is used in patients who have already had a TIA or minor stroke attributable to ipsilateral carotid disease and in those with asymptomatic high-grade stenosis who are considered high surgical risk for open endarterectomy.